Diagnosis of cryptantigen exposure and polyagglutinability: management of transfusion therapy in a patient with sepsis and colitis.
Rodwell
R
R
Haematology Division, Mater Misericordiae Hospital, South Brisbane, Qld.
Lavercombe
P
P
Taylor
K M
KM
Freney
R
R
Haffenden
M
M
Liew
Y W
YW
Jayaswal
U
U
D000368:Aged; D001424:Bacterial Infections / Q000097:blood / Q000628:therapy*; D016360:Clostridioides difficile; D004761:Enterocolitis, Pseudomembranous / Q000097:blood / Q000382:microbiology / Q000628:therapy*; D017707:Erythrocyte Transfusion; D004912:Erythrocytes / Q000276:immunology / Q000502:physiology*; D004927:Escherichia coli Infections / Q000276:immunology; D005260:Female; D006384:Hemagglutination; D006461:Hemolysis; D006801:Humans; D007519:Isoantigens / Q000032:analysis*; D011552:Pseudomonas Infections / Q000276:immunology; D011550:Pseudomonas aeruginosa; D013102:Spherocytes / Q000502:physiology; D013203:Staphylococcal Infections / Q000276:immunology; D013249:Sternum / Q000382:microbiology / Q000601:surgery; D013530:Surgical Wound Infection / Q000276:immunology; D014312:Trisaccharides / Q000032:analysis*
D007519:Isoantigens; C064068:Thomsen-Friedenreich antigen, cryptic; D014312:Trisaccharides